ASGCT Opens Group's Largest-Ever Annual Meeting

The 21st Annual Meeting of the American Society of Gene and Cell Therapy, the first in Chicago and the largest in ASGCT, opens today to more than 3,100 pre-registered attendees to take in nearly 1,000 new research and clinical trial abstracts.

CHICAGO (PRWEB) May 16, 2018

The 21st Annual Meeting of the American Society of Gene & Cell Therapy, the first in Chicago, opens today to more than 3,100 pre-registered attendees to take in nearly 1,000 new research and clinical trial abstracts.

When the doors open on ASGCT's annual meeting at 7 a.m. Wednesday morning, May 16, it will already be the largest in the history of the Society thanks to the thousands of pre-registered attendees and the hundreds of industry sponsors and exhibitors. Registration will be open on-site throughout the duration of the meeting for those who would still like to attend.

The schedule of ASGCT's 21st Annual Meeting and the full collection of abstracts are available online.

For more information about the ASGCT Annual Meeting, please contact Digital Communications Manager Alex Wendland at awendland@asgct.org.

About The American Society of Gene & Cell Therapy
ASGCT is the primary membership organization for scientists, physicians, professionals, and patient advocates involved in gene and cell therapy. The Society’s mission is to advance knowledge, awareness, and education leading to discovery and clinical application of gene and cell therapies to alleviate disease. ASGCT’s vision is to serve as a catalyst to transform medicine by advancing gene and cell therapies to benefit patients and society.

For the original version on PRWeb visit: http://www.prweb.com/releases/2018/05/prweb15483882.htm